Description:

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Keywords:
Versions (1) ▾
  1. 6/11/17
Copyright Holder:
Genentech, Inc.
Uploaded on:

June 11, 2017

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CONCURRENT OCULAR PROCEDURES (DAY 0 - MONTH 12) CRFs Roche FVF4170G Macular Edema NCT00473382

CONCURRENT OCULAR PROCEDURES (DAY 0 - MONTH 12) CRFs Roche FVF4170G Macular Edema NCT00473382

Patient administration
CONCURRENT OCULAR PROCEDURES (DAY 0 - MONTH 12)
Any concurrent ocular procedures performed other than FOCAL, GRID, and Pan Retinal Photocoagulation (PRP) Laser?
Procedure
DD/MMM/YY
Right Eye
Left Eye
Disease Category Code
Procedure Outcome Stable?